Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase III Trial Comparing Hepatic Arterial Injection of Yttrium-90 Resin Microspheres (SIR-spheres) Plus Systemic Maintenance Therapy Versus Systemic Maintenance Therapy Alone for Patients With Unresectable Liver Metastases From Colorectal Cancer Which Are Controlled After Induction Systemic Therapy

NCT01895257 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT01895257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01895257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase III Trial Comparing Hepatic Arterial Injection of Yttrium-90 Resin Microspheres (SIR-spheres) Plus Systemic Maintenance Therapy Versus Systemic Maintenance Therapy Alone for Patients With Unresectable Liver Metastases From Colorectal Cancer Which Are Controlled After Induction Systemic Therapy
Lead sponsor
Universiteit Antwerpen
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2013
Completion date
December 31, 2018
Enrollment
162 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer